Context Therapeutics Inc.
CNTX • NASDAQ
Context Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Martin A. Lehr, with a market cap of $238.0M.
CEOMartin A. Lehr
Next Earnings
Upcoming earnings announcement for Context Therapeutics Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Earnings History
Past 12 earnings reports for Context Therapeutics Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$0.14Est: -$0.11 | -27.3% | -Est: -$1.5M | +100.0% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.10Est: -$0.09 | -11.1% | -Est: -$1.4M | +100.0% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.09Est: -$0.06 | -50.0% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.05Est: -$0.06 | +16.7% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | $0.00Est: -$0.06 | +100.0% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.22Est: -$0.09 | -144.4% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.04Est: -$0.07 | +42.9% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.23Est: -$0.38 | +39.5% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.42Est: -$0.35 | -20.0% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.37 | — | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.31 | — | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.40 | — | - | — | — |